If you are considering applying for a grant and your organization is located outside the United States click here

Applying for a Grant

Lilly provides grants and charitable contributions for healthcare professional education, patient advocacy and consumer education programs in a variety of therapeutic areas through the Lilly Grant Office. Our commitment is to make grant funding available for independent, fair and balanced, scientifically accurate initiatives that receive no influence from our organization in either submission, design, or implementation. Regardless of whether CME or CE credits are offered for healthcare professional participation, Lilly expects that the same high standards apply for all independent educational activities for healthcare professionals.

Additionally, Lilly has entered into partnerships and alliances with other pharmaceutical companies and established grant offices to support continuing medical education for healthcare professionals in specific therapeutic areas.

The application process for all of our grant offices is online. Detailed information about how to register and apply, including documentation requirements, review process, and decision notification, is available in each of the online grant application and management portals.

Important note:

Any organization found to be listed on the Office of Inspector General's List of Excluded Individuals/Entities (OIG LEIE) or the General Services Administration Excluded Parties List System (GSA EPLS) will not be allowed to receive a grant. Requesting organizations will be required to accept all terms and conditions of the grant application process.

Lilly Logo

Lilly Grant Office

Eli Lilly and Company is committed to improving patient care and providing valuable information to the medical and broader healthcare community. Lilly accepts requests for healthcare professional education, patient advocacy and consumer education programs. Our areas of focus include: autoimmune, endocrine, neurodegeneration, neuroscience - migraine and headache disorders, and oncology.

Apply: Lilly Grant Office

Partners in Diabetes

Boehringer logo

Boehringer Ingelheim – Lilly Grant Office

On January 11, 2011, Boehringer Ingelheim Pharmaceutical Inc. (BIPI) and Lilly announced a global agreement to jointly develop a portfolio of diabetes compounds. We are committed to supporting education that fosters innovative, high quality, independent medical education for healthcare professionals and patients that narrows unmet medical needs, maintains clinical excellence, and measurably improves health outcomes in areas of interest to the BIPI and Lilly Diabetes Alliance.

Apply: Boehringer Ingelheim - Lilly Grant Office